Peptide Database
A verified index of sequences, half-lives, and molecular weights curated for the research community.
Showing 5 peptides in GLP-1 / Weight Loss
Semaglutide
FDA ApprovedGLP-1 / Weight Loss
A GLP-1 receptor agonist used for type 2 diabetes and weight management. One of the most studied peptides for metabolic health.
Molecular Weight
4113.6 Da
Half-Life
~7 days
Tirzepatide
FDA ApprovedGLP-1 / Weight Loss
A dual incretin agonist targeting both GIP and GLP-1 receptors. Shows superior weight loss and glycemic control compared to GLP-1-only agonists.
Molecular Weight
4813.5 Da
Half-Life
~5 days
AOD-9604
TGA Approved (Australia, oral)GLP-1 / Weight Loss
A modified fragment of human growth hormone (amino acids 177-191) that stimulates lipolysis without the growth-promoting or diabetogenic effects of full GH.
Molecular Weight
1815.1 Da
Half-Life
~6-8 hours
Retatrutide
Phase 3 Clinical TrialsGLP-1 / Weight Loss
A triple-hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Shows the highest weight loss of any obesity drug in trials.
Molecular Weight
~4700 Da
Half-Life
~6 days
Cagrilintide
Phase 3 Clinical TrialsGLP-1 / Weight Loss
A long-acting amylin analog being developed in combination with semaglutide (CagriSema) for obesity and type 2 diabetes treatment.
Molecular Weight
~3950 Da
Half-Life
~7 days